News | February 19, 2007

Cordis Releases New Version Carotid Stenting System

FDA has granted approval to the Cordis Endovascular division of Cordis Corp. to market its PRECISE RX Nitinol Self-Expanding Stent and ANGIOGUARD RX Emboli Capture Guidewire System to treat clogged neck arteries. The approval was announced during the Arizona Heart Institute's International Congress on Endovascular Interventions in Scottsdale, AZ.
The PRECISE RX Nitinol Self-Expanding Stent and ANGIOGUARD RX Emboli Capture Guidewire System differ are from Cordis' over-the-wire carotid system approved last year — the RX, or rapid exchange, version facilitates single operator use and more efficient manipulation of the catheter and guidewire during stenting procedures.

Anil Chhabra, M.D., Willis Knighton Medical Center in Shreveport, LA, performed the first U.S. carotid case with the newly approved carotid stent and emboli protection system.

Cordis Endovascular also announced the initiation of SAPPHIRE Worldwide, a 10,000 patient global registry to assess the 30-day rate of major adverse events (death, stroke or myocardial infarction) following the placement of a stent in high surgical risk patients with carotid artery disease. The stent procedure includes use of an emboli distal protection system — designed to contain and remove plaque or debris from the artery during the procedure.

The registry will include up to 275 centers with low, medium and high annual carotid stent implant volumes, from both academic and private hospitals.

Related Content

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid| November 18, 2016
November 18, 2016 — InspireMD Inc.
transcarotid artery revascularization, TCAR Surveillance Project, Society for Vascular Surgery Patient Safety Organization, SVS PSO,
News | Stents Carotid| October 13, 2016
A surveillance project to evaluate the safety and effectiveness of transcarotid artery revascularization (TCAR) in...
CREST trial results, New England Journal of Medicine, stenting, endarterectomy, carotid artery stenosis
News | Cath Lab| March 04, 2016
Recent results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) are evidence that...
carotid artery stenting, outcomes, JACC, Beau Hawkins, Robert Yeh, CARE Registry
Feature | Stents Carotid| July 13, 2015
Hospitals performing carotid artery stenting vary considerably in rates of in-hospital stroke or death, according to a...
News | Stents Carotid| June 17, 2015
Karam Moon, M.D., winner of the DePuy Synthes Cerebrovascular Section Resident/Fellow Award, presented his research,...
Technology | June 01, 2015
Silk Road Medical Inc. announced the company received U.S. Food & Drug Administration (FDA) 510(k) clearance for...
carotid artery stenting, F-EPD, P-EPD, ACC, embolic protection devices
News | April 22, 2015
A study published in JACC: Cardiovascular Interventions showed that in-hospital and 30-day stroke or death rates were...
VIVA, VIVA Physicians, Peripheral, Carotid Artery Device, clinical trial results
Feature | November 11, 2014
Viva Physicians, a not-for-profit organization in the field of vascular medicine and intervention, announce clinical...
Overlay Init